lactic acid has been researched along with emtricitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melkaoui, K; Setzer, B; Venhoff, N; Walker, UA | 1 |
| Pai, RS; Singh, G | 2 |
3 other study(ies) available for lactic acid and emtricitabine
| Article | Year |
|---|---|
Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dideoxynucleosides; DNA, Mitochondrial; Emtricitabine; Humans; Lactic Acid; Lipid Metabolism; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2007 |
Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine.
Topics: Animals; Antiviral Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Deoxycytidine; Drug Delivery Systems; Drug Stability; Emtricitabine; Excipients; Lactic Acid; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Reproducibility of Results; Tissue Distribution | 2014 |
Optimization (central composite design) and validation of HPLC method for investigation of emtricitabine loaded poly(lactic-co-glycolic acid) nanoparticles: in vitro drug release and in vivo pharmacokinetic studies.
Topics: Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Deoxycytidine; Emtricitabine; In Vitro Techniques; Lactic Acid; Limit of Detection; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet | 2014 |